Related Experiment Video
Updated: Aug 5, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Exploring Heterogeneity in Meta-Analysis Using Trial-Level Characteristics: A Tutorial
Peter J Godolphin1, Conor D Tweed1, David J Fisher1
1UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology University College London London UK.
Cochrane Evidence Synthesis and Methods
|August 4, 2026
Summary
Explore across-trial heterogeneity in meta-analysis using trial-level characteristics. This tutorial covers subgroup analysis and meta-regression, including interpretation and common pitfalls.
Area of Science:
- Biostatistics
- Medical Research Methodology
Background:
- Understanding heterogeneity is crucial in meta-analysis.
- Trial-level characteristics can explain variations between studies.
Purpose of the Study:
- To provide a tutorial on exploring across-trial heterogeneity in meta-analysis.
- To guide users on utilizing trial-level characteristics for subgroup analysis and meta-regression.
Main Methods:
- Describes subgroup analysis for categorical trial-level characteristics (>2 categories).
- Presents approaches for analyzing continuous trial-level characteristics.
- Introduces meta-regression, its applications, and interpretation.
Main Results:
- Provides practical guidance on conducting and interpreting subgroup analyses.
- Explains how to perform and interpret meta-regression.
- Highlights common pitfalls in these analyses.
Conclusions:
- Effective use of trial-level characteristics enhances meta-analysis interpretation.
- Subgroup analysis and meta-regression are key tools for exploring heterogeneity.
- Awareness of potential pitfalls improves the reliability of meta-analysis results.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:15Study Design in Statistics
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...